"The voice for cancer physicians and their patients in Massachusetts."
The U.S. Food and Drug Administration approved ibrutinib (Imbruvica; Pharmacyclics) plus rituximab (Rituxan) for the treatment of adult patients with Waldenstrom's macroglobulinemia (WM). Read full press release.
Massachusetts Society of Clinical Oncologists (c) 860 Winter Street, Waltham, MA. 02451
Waltham, MA. 02451